American Anti-Psychotic

Post image for American Anti-Psychotic

by Screedler on November 13, 2014

Have Americans in mass gone off their rockers. Apparently so, the U.S. top money-making drug has been crowned, and it’s not an allergy medicine or an erectile dysfunction medication. You have definitely heard of it, but may not know what it really is. To watch the ads on TV, you would think it’s the drug equivalent of Sriracha; just something you add to your anti-depressant of choice and give it a little kick. It’s the powerful anti-psychotic drug Abilify. Patrick Bateman would be so proud. Anyone who watches TV knows it is a modern day mother’s little helper, hawked by cutesy animated pills, an overwhelmed everywoman, and caring and concerned medical professionals, family, and friends.

While Abilify’s advertising depicts it as a kind of supplement to anti-depressants, with sad women giving it a try when the Prozac or Zoloft or Xanax does not seem to help, Abilify actually is like a bazooka to a conventional anti-depressants’ revolver. Critics have argued that anti-psychotics don’t treat anything at all; they just zone people out so they don’t notice much. They’re effective in the short term, but essentially, that’s because they are really just powerful tranquilizers. This makes sense for their primary use: anti-psychotics like aripiprazole are administered to seriously ill people like schizophrenics. Abilify is a close cousin of Thorazine. Yet, now it’s the most profitable drug in America.

For an alarming read on what Abilify is and how it works (nobody knows) check out the this article over at The Daily Beast:   Mother’s Little Anti-Psychotic

From WebMD:

[column width=”240px” padding=”10px”]The top 10 drugs by number of monthly prescriptions are:

Synthroid, 22.6 million
Crestor, 22.5 million
Nexium, 18.6 million
Ventolin HFA, 17.5 million
Advair Diskus, 15.0 million
Diovan, 11.4 million
Lantus Solostar, 10.1 million
Cymbalta, 10.0 million
Vyvanse, 10.0 million
Lyrica, 9.6 million[/column]

[column width=”260px” padding=”10px”]The top 10 drugs by sales are:

Abilify, $7.2 billion
Humira, $6.3 billion
Nexium, $6.3 billion
Crestor, $5.6 billion
Enbrel, $5.0 billion
Advair Diskus, $5.0 billion
Sovaldi, $4.4 billion
Remicade, $4.3 billion
Lantus Solostar, $3.8 billion
Neulasta, $3.6 billion[/column]
[end_columns]

{ 0 comments… add one now }

Leave a Comment

{ 1 trackback }

Previous post:

Next post: